2020
DOI: 10.1186/s12890-020-01268-7
|View full text |Cite
|
Sign up to set email alerts
|

Regional emphysema score is associated with tumor location and poor prognosis in completely resected NSCLC patients

Abstract: Background Lung cancer is a frequent comorbidity of chronic obstructive pulmonary disease (COPD). However, the local risk of developing lung cancer related to regional emphysema distribution and clinical outcome has not been investigated. Our aim was to evaluate the impact of regional emphysema score (RES) on tumor location and prognosis in non-small cell lung cancer (NSCLC) patients. Methods We enrolled 457 patients who underwent curative surgery for NSCLC at seven hospitals at The Catholic University of Ko… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
12
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
6
1

Relationship

3
4

Authors

Journals

citations
Cited by 8 publications
(12 citation statements)
references
References 49 publications
0
12
0
Order By: Relevance
“…Tumor grade was served as a prognostic factor in non-small cell lung cancer patients, according to previous studies ( 16 , 17 ). However, previous studies were mainly aimed at the squamous cell carcinoma or adenocarcinoma population, and there is a lack of research on the effect of tumor differentiation on the prognosis of ASC patients.…”
Section: Discussionmentioning
confidence: 99%
“…Tumor grade was served as a prognostic factor in non-small cell lung cancer patients, according to previous studies ( 16 , 17 ). However, previous studies were mainly aimed at the squamous cell carcinoma or adenocarcinoma population, and there is a lack of research on the effect of tumor differentiation on the prognosis of ASC patients.…”
Section: Discussionmentioning
confidence: 99%
“…The inclusion criteria were pathologically confirmed primary NSCLC, no relapse up to 12 months after surgery, and R0 resection. Relapse was defined based on radiological or histological evidence of cancer within 12 months after treatment [ 18 , 19 ]. The study included 238 patients who underwent pulmonary function test (PFT) during the evaluation period (6 ± 3 months).…”
Section: Methodsmentioning
confidence: 99%
“…FEV 1 , FEV 1 /forced vital capacity (FVC), the diffusing capacity of the lung for carbon monoxide (DL CO ), and the residual volume (RV)/total lung capacity (TLC) were measured three times: before surgery, 6 ± 3 months (abbreviated as 6 months for convenience) after surgery, and 12 ± 3 months (abbreviated as 12 months) after surgery. Based on smoking history, the patients were grouped into never smokers if they never smoked or if they had smoked less than 100 cigarettes in their lifetime, and ever smokers if they had smoked at least 100 cigarettes in their lifetime [ 18 , 21 ]. PFT was performed in accordance with the American Thoracic Society/European Respiratory Society standardization guidelines.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…To analyze the differences between the 48 lung cancer patients who had active pulmonary TB and the patients without TB, we used the data from 575 lung cancer patients collected at the same hospital during the same period. This study used the Catholic Medical Center (CMC) lung cancer registry containing data from seven hospitals ( (14)(15)(16). We analyzed data of the lung cancer patients without TB diagnosed at Seoul, Eunpyeong, Bucheon, and Uijeongbu from January 2009 to December 2017.…”
Section: Registry Datamentioning
confidence: 99%